Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | AGER | Q15109 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | DHODH | Q02127 | 2/20 | 0.50 |
| ▸ | MYC | P01106 | 1/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | KDM6B | O15054 | 1/20 | 0.46 |
| ▸ | KDM6A | O15550 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29442955 | 1.00 | KDM4E (0.63) | KDM4ETDP1ALDH1A1ALOX15L3MBTL1 | |
| Hydrochloric Acid SCHEMBL10560254 | 0.98 | KDM4E (0.61) | KDM4ETDP1ALDH1A1ALOX15L3MBTL1 | |
| Glycine SCHEMBL28318151 | 0.89 | NAPRT (0.53) | KDM4ETDP1ALDH1A1ALOX15L3MBTL1 | |
| SCHEMBL28317159 | 0.81 | NAPRT (0.45) | KDM4ETDP1ALDH1A1ALOX15L3MBTL1 | |
| SCHEMBL1972194 | 0.81 | SMN1; SMN2 (0.47) | KDM4ETDP1ALDH1A1ALOX15L3MBTL1 | |
| SCHEMBL30320721 | 0.81 | KDM4E (0.45) | KDM4ETDP1ALDH1A1ALOX15L3MBTL1 | |
| SCHEMBL1379678 | 0.81 | PARP1 (0.56) | KDM4ETDP1ALDH1A1ALOX15L3MBTL1 | |
| SCHEMBL365580 | 0.81 | KDM4E (0.45) | KDM4ETDP1ALDH1A1ALOX15L3MBTL1 | |
| SCHEMBL30040285 | 0.81 | PARP1 (0.56) | KDM4ETDP1ALDH1A1ALOX15L3MBTL1 | |
| SCHEMBL4707275 | 0.80 | AKR1C3 (0.52) | KDM4ETDP1ALDH1A1ALOX15L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 670 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115521249-B | 2- [4- (1-Oxo alkyl) phenoxy ] -3-picolinic acid, preparation method and application thereof | 沈阳兴齐眼药股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| US-20240343738-A1 | Method for preparing pranoprofen and composition comprising pranoprofen and impurity | SHENYANG XINGQI PHARMACEUTICAL CO., LTD. (CN) | 2024-10-17 | — | — | US | claimed |
| EP-4361155-A1 | METHOD FOR PREPARING PRANOPROFEN AND COMPOSITION CONTAINING PRANOPROFEN AND IMPURITY | Shenyang Xingqi Pharmaceutical Co., Ltd. (CN) | 2024-05-01 | — | — | EP | claimed |
| CN-114181179-B | Compound containing naphthoquinone oxime structure and medical application of compound as bombesin receptor subtype-3 agonist | 上海交通大学 | 2023-11-24 | — | — | CN | claimed |
| WO-2022267945-A1 | METHOD FOR PREPARING PRANOPROFEN AND COMPOSITION CONTAINING PRANOPROFEN AND IMPURITY | 沈阳兴齐眼药股份有限公司 | 2022-12-29 | — | — | WO | claimed |
| CN-115521249-A | 2- [4- (1-oxoalkyl) phenoxy ] -3-picolinic acid, preparation method and application thereof | 沈阳兴齐眼药股份有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-114181179-A | Compound containing naphthoquinone oxime structure and medical application of compound as bombesin receptor subtype-3 agonist | 上海交通大学 | 2022-03-15 | — | — | CN | claimed |
| CN-112375032-A | Synthetic method of 3-aminopyridine formaldehyde | 苏州康润医药有限公司 | 2021-02-19 | — | — | CN | claimed |
| CN-110317204-A | Pyrazolopyrimidinonefor derivative and its preparation method and application | 安徽农业大学 | 2019-10-11 | — | — | CN | claimed |
| CN-104945316-B | A kind of method of microwave method synthesis 2- halos nicotinate and its intermediate | 山东师范大学 | 2018-05-04 | — | — | CN | claimed |
| CN-104945317-B | A kind of method of supercritical ultrasonics technology synthesis 2- halos nicotinate and its intermediate | 山东师范大学 | 2018-03-30 | — | — | CN | claimed |
| CN-107033525-A | A kind of anti-fire composite engineering plastics | 郑州源冉生物技术有限公司 | 2017-08-11 | — | — | CN | claimed |
| CN-106751391-A | A kind of anti-fire high-performance composite engineering plastics | 郑州源冉生物技术有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106751852-A | A kind of heat-proof combustion-resistant engineering plastics | 姚旭 | 2017-05-31 | — | — | CN | claimed |
| CN-106633619-A | Modified engineering plastic | 郑州北斗七星通讯科技有限公司 | 2017-05-10 | — | — | CN | claimed |
| US-20260103454-A1 | MODULATORS OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC (US) | 2026-04-16 | — | — | US | disclosed |
| US-12570655-B2 | Cysteine covalent modifiers of AKT1 and uses thereof | TERREMOTO BIOSCIENCES, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-3992536-A | SEDATIVES AND MUSCLE RELAXANTS | BOEHRINGER INGELHEIM GMBH (DT) | 1976-11-16 | — | — | US | disclosed |
| US-3966736-A | 2,9-Dihydro-3H-pyrido[3,2-c]-s-triazolo[4,3-a][1,5]-benzodiazepin-3-ones | THE UPJOHN COMPANY (US) | 1976-06-29 | — | — | US | disclosed |
| US-3931185-A | SEDATIVES, MUSCLE RELAXANT | BOEHRINGER INGELHEIM GMBH (DT) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570655-B2 | Cysteine covalent modifiers of AKT1 and uses thereof | AKT1, AKT2, AKT3 | KDM4E 2962/4885TDP1 3565/4885ALDH1A1 3594/4885 |
| US-20240343738-A1 | Method for preparing pranoprofen and composition comprising pranoprofen and impurity | CYP3A5, CYP3A43, CYP4A11 | KDM4E 3123/4885TDP1 991/4885ALDH1A1 205/4885 |
| US-20260103454-A1 | MODULATORS OF HEMOGLOBIN | HBZ, HBB, HBG2 | KDM4E 799/4885TDP1 3514/4885ALDH1A1 1843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.